Company: HCTI
Filing Date: 2025-11-19
Form Type: 424B5
Source: 0001213900-25-112544
Chunk: 24

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-19
Form: 424B5
Chunk 24
---
 replace statements in and portions of this prospectus or the above
listed documents.

We will provide you without charge, upon your
written or oral request, a copy of any of the documents incorporated by reference in this prospectus, other than exhibits to such documents
which are not specifically incorporated by reference into such documents. Please direct your written or telephone requests to:

<div align='center'>Healthcare Triangle, Inc.

Attn: Investor Relations

7901 Stoneridge Drive, Suite 220

Pleasanton, CA 94588

(925) 270-4812

S-13</div>

Prospectus

<div align='center'>$ 50,000,000

HEALTHCARE TRIANGLE, INC.

Common Stock

Preferred Stock

Warrants

Debt Securities

Rights

Units</div>

This prospectus will allow us to issue, from time
to time at prices and on terms to be determined at or prior to the time of the offering, up to $50,000,000 of any combination of the securities
described in this prospectus, either individually or in units. We may also offer common stock or preferred stock upon conversion of or
exchange for the debt securities; common stock upon conversion of or exchange for the preferred stock; common stock, preferred stock or
debt securities upon the exercise of warrants, rights or performance of purchase contracts; or any combination of these securities upon
the performance of purchase contracts.

This prospectus describes the general terms of
these securities and the general manner in which these securities will be offered. We will provide you with the specific terms of any
offering in one or more supplements to this prospectus. The prospectus supplements will also describe the specific manner in which these
securities will be offered and may also supplement, update or amend information contained in this document. You should read this prospectus
and any prospectus supplement, as well as any documents incorporated by reference into this prospectus or any prospectus supplement, carefully
before you invest.

Our securities may be sold directly by us to you,
through agents designated from time to time or to or through underwriters or dealers. For additional information on the methods of sale,
you should refer to the section entitled “Plan of Distribution” in this prospectus and in the applicable prospectus
supplement. If any underwriters or agents are involved in the sale of our securities with respect to which this prospectus is being delivered,
the names of such underwriters or agents and any